Neuphoria Therapeutics (NEUP) Liabilities and Shareholders Equity (2020 - 2026)
Neuphoria Therapeutics' Liabilities and Shareholders Equity was $28.71 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 0.4% from $28.59 million a year earlier but down 17.5% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
From fiscal Q4 2020 onward, Neuphoria Therapeutics has reported Liabilities and Shareholders Equity for 13 quarters.
- Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -7.2% (FY2021 to FY2026).
- In earlier fiscal years, Liabilities and Shareholders Equity was $28.59 million in FY2025 (+3.4%), $27.65 million in FY2024 (-3.8%), $28.74 million in FY2023 (-38.6%) and $46.78 million in FY2022 (+12.0%).
- Quarterly Liabilities and Shareholders Equity has moved between $18.17 million (fiscal Q2 2025) and $46.78 million (fiscal Q4 2022) over five years.
- Compared with a year earlier, Liabilities and Shareholders Equity has increased for five straight quarters, with growth averaging 27.6% over the last five quarters.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was fiscal Q2 2026 (growth of 101.4%); the worst was fiscal Q4 2023 (a decline of 38.6%).
- Per Business Quant data, NEUP's Liabilities and Shareholders Equity in the three fiscal quarters before Q4 2026 was $34.81 million (Q3 2026), $36.6 million (Q2 2026) and $27.34 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.40 Bn | 1,140.99 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 642.90 Bn | 561.42 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 375.88 Bn | 330.26 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.81 Bn | 266.80 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 268.58 Bn | 242.27 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 242.38 Bn | 197.78 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.63 Bn | 167.83 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Neuphoria Therapeutics | 436.98 Mn | 361.78 Mn | - | 28.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.71 Mn |
| Mar 31, 2026 | 34.81 Mn |
| Dec 31, 2025 | 36.60 Mn |
| Sep 30, 2025 | 27.34 Mn |
| Jun 30, 2025 | 28.59 Mn |
| Mar 31, 2025 | 30.71 Mn |
| Dec 31, 2024 | 18.17 Mn |
| Sep 30, 2024 | 22.92 Mn |
| Jun 30, 2024 | 27.65 Mn |
| Jun 30, 2023 | 28.47 Mn |
| Jun 30, 2022 | 44.94 Mn |
| Jun 30, 2021 | 40.77 Mn |
| Jun 30, 2020 | 750,529.14 |
API Access
Neuphoria Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();